Global Antibiotics Market Size study, by Action Mechanism (Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, DNA Synthesis Inhibitors, RNA Synthesis Inhibitors, and Mycolic Acid Inhibitors) Drug Class (Cephalosporin, Penicillin, Fluoroquinolone, Macrolide, Carbapenem, Aminoglycoside, Sulfonamide, and 7-ACA) and Regional Forecasts 2021-2027

BIZ4355383
200 Pages
May 2021
Pharmaceuticals

Download Sample Get Discount

Global Antibiotics Market is valued approximately USD 40.85 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 4.6 % over the forecast period 2021-2027. Antibiotics are the anti-microbial that destroy or slows down the growth of bacteria. Antibiotics are available in different forms like pills, capsules, syrups or injections. The increasing investments in research and development of new antibiotic drugs, increasing growth in the incidences of infection and chronic diseases and constant support from the governments for the development of antibacterial drugs have been driving the global market across the forecast period. There have been continuous efforts of pharmaceutical companies in development of new antibiotics which are more susceptible in nature. According to a report published by Proceedings of the National Academy of Science (PNAS), the consumption rate of antibiotics increased by 39% during the period of 2000-2015, whichis further expected to increase by 200% by 2030. As per the report of World Health Organization (WHO), around 10 million cases of tuberculosis were diagnosed in 2019, leading to increased consumption of antibiotics. However, strict government regulations for the approval of new medicines and certain side effects of antibiotics can hamper the growth of the market over the forecast period of 2021-2027. Whereas, prolonged increase in the demand of antibiotics is likely to increase the market growth during the forecast period.

The regional analysis of global Natural Extracts market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Asia-Pacific holds the largest market share. This is mainly because of an increase in the number of prescriptions of antibiotics as well as the larger population in the region. Whereas, North America is also expected to project remarkable growth over the upcoming period 2021-2027. Factors such as the availability of many pharmaceutical manufacturers and improving healthcare infrastructure would help North America to outpace the Antibiotics Market.

Major market player included in this report are:

Allergan (AbbVie Inc.)

Merck & Co., Inc

Cumberland Pharmaceuticals, Inc.

GlaxoSmithKline plc

Novartis AG

Melinta Therapeutics

Teva Pharmaceutical Industries Ltd.

Nabriva Therapeutics plc

Mylan N.V.

Abbott Laboratories

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Action Mechanism:

Cell Wall Synthesis Inhibitors

Protein Synthesis Inhibitors

DNA Synthesis Inhibitors

RNA Synthesis Inhibitors

Mycolic Acid Inhibitors

Others

By Drug Class:

Cephalosporin

Penicillin

Fluoroquinolone

Macrolide

Carbapenem

Aminoglycoside

Sulfonamide

7-ACA

Others

By Region:

North America

U.S.

Canada

Europe

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019

Base year – 2020

Forecast period – 2021 to 2027

Target Audience of the Global Antibiotics Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)

1.2.1. Antibiotics Market, by Region, 2019-2027 (USD Billion)

1.2.2. Antibiotics Market, by Action Mechanism, 2019-2027 (USD Billion)

1.2.3. Antibiotics Market, by Drug Class, 2019-2027 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Antibiotics Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Antibiotics Market Dynamics

3.1. Antibiotics Market Impact Analysis (2019-2027)

3.1.1. Market Drivers

3.1.1.1. Investments in research and development of new antibiotic drugs

3.1.1.2. Increasing growth in the incidences of infection and chronic diseases

3.1.1.3. Constant support from the governments

3.1.2. Market Challenges

3.1.2.1. Strict government regulations for the approval of new medicines

3.1.2.2. Certain side effects of antibiotics

3.1.3. Market Opportunities

3.1.3.1. Prolonged increase in the demand of antibiotics

Chapter 4. Global Antibiotics Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Antibiotics Market, by Action Mechanism

5.1. Market Snapshot

5.2. Global Antibiotics Market by Action Mechanism , Performance - Potential Analysis

5.3. Global Antibiotics Market Estimates & Forecasts by Action Mechanism 2018-2027 (USD Billion)

5.4. Antibiotics Market, Sub Segment Analysis

5.4.1. Cell Wall Synthesis Inhibitors

5.4.2. Protein Synthesis Inhibitors

5.4.3. DNA Synthesis Inhibitors

5.4.4. RNA Synthesis Inhibitors

5.4.5. Mycolic Acid Inhibitors

5.4.6. Others

Chapter 6. Global Antibiotics Market, by Drug Class

6.1. Market Snapshot

6.2. Global Antibiotics Market by Drug Class, Performance - Potential Analysis

6.3. Global Antibiotics Market Estimates & Forecasts by Drug Class 2018-2027 (USD Billion)

6.4. Antibiotics Market, Sub Segment Analysis

6.4.1. Cephalosporin

6.4.2. Penicillin

6.4.3. Fluoroquinolone

6.4.4. Macrolide

6.4.5. Carbapenem

6.4.6. Aminoglycoside

6.4.7. Sulfonamide

6.4.8. 7-ACA

6.4.9. Others

Chapter 7. Global Antibiotics Market, Regional Analysis

7.1. Antibiotics Market, Regional Market Snapshot

7.2. North America Antibiotics Market

7.2.1. U.S. Antibiotics Market

7.2.1.1. Action Mechanism breakdown estimates & forecasts, 2018-2027

7.2.1.2. Drug Class breakdown estimates & forecasts, 2018-2027

7.2.2. Canada Antibiotics Market

7.3. Europe Antibiotics Market Snapshot

7.3.1. U.K. Antibiotics Market

7.3.2. Germany Antibiotics Market

7.3.3. France Antibiotics Market

7.3.4. Spain Antibiotics Market

7.3.5. Italy Antibiotics Market

7.3.6. Rest of Europe Antibiotics Market

7.4. Asia-Pacific Antibiotics Market Snapshot

7.4.1. China Antibiotics Market

7.4.2. India Antibiotics Market

7.4.3. Japan Antibiotics Market

7.4.4. Australia Antibiotics Market

7.4.5. South Korea Antibiotics Market

7.4.6. Rest of Asia Pacific Antibiotics Market

7.5. Latin America Antibiotics Market Snapshot

7.5.1. Brazil Antibiotics Market

7.5.2. Mexico Antibiotics Market

7.6. Rest of The World Antibiotics Market

Chapter 8. Competitive Intelligence

8.1. Top Market Strategies

8.2. Company Profiles

8.2.1. Allergan (AbbVie Inc.)

8.2.1.1. Key Information

8.2.1.2. Overview

8.2.1.3. Financial (Subject to Data Availability)

8.2.1.4. Product Summary

8.2.1.5. Recent Developments

8.2.2. Merck & Co., Inc

8.2.3. Cumberland Pharmaceuticals, Inc.

8.2.4. GlaxoSmithKline plc

8.2.5. Novartis AG

8.2.6. Melinta Therapeutics

8.2.7. Teva Pharmaceutical Industries Ltd.

8.2.8. Nabriva Therapeutics plc

8.2.9. Mylan N.V.

8.2.10. Abbott Laboratories

Chapter 9. Research Process

9.1. Research Process

9.1.1. Data Mining

9.1.2. Analysis

9.1.3. Market Estimation

9.1.4. Validation

9.1.5. Publishing

9.2. Research Attributes

9.3. Research Assumption

List of Tables

TABLE 1. Global Antibiotics market, report scope

TABLE 2. Global Antibiotics market estimates & forecasts by Region 2018-2027 (USD Billion)

TABLE 3. Global Antibiotics market estimates & forecasts by Action Mechanism 2018-2027 (USD Billion)

TABLE 4. Global Antibiotics market estimates & forecasts by Drug Class 2018-2027 (USD Billion)

TABLE 5. Global Antibiotics market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 6. Global Antibiotics market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 7. Global Antibiotics market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 8. Global Antibiotics market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 9. Global Antibiotics market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 10. Global Antibiotics market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 11. Global Antibiotics market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 12. Global Antibiotics market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 13. Global Antibiotics market by segment, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 14. Global Antibiotics market by region, estimates & forecasts, 2018-2027 (USD Billion)

TABLE 15. U.S. Antibiotics market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 16. U.S. Antibiotics market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 17. U.S. Antibiotics market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 18. Canada Antibiotics market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 19. Canada Antibiotics market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 20. Canada Antibiotics market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 21. UK Antibiotics market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 22. UK Antibiotics market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 23. UK Antibiotics market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 24. Germany Antibiotics market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 25. Germany Antibiotics market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 26. Germany Antibiotics market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 27. RoE Antibiotics market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 28. RoE Antibiotics market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 29. RoE Antibiotics market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 30. China Antibiotics market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 31. China Antibiotics market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 32. China Antibiotics market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 33. India Antibiotics market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 34. India Antibiotics market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 35. India Antibiotics market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 36. Japan Antibiotics market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 37. Japan Antibiotics market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 38. Japan Antibiotics market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 39. RoAPAC Antibiotics market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 40. RoAPAC Antibiotics market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 41. RoAPAC Antibiotics market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 42. Brazil Antibiotics market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 43. Brazil Antibiotics market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 44. Brazil Antibiotics market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 45. Mexico Antibiotics market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 46. Mexico Antibiotics market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 47. Mexico Antibiotics market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 48. RoLA Antibiotics market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 49. RoLA Antibiotics market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 50. RoLA Antibiotics market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 51. Row Antibiotics market estimates & forecasts, 2018-2027 (USD Billion)

TABLE 52. Row Antibiotics market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 53. Row Antibiotics market estimates & forecasts by segment 2018-2027 (USD Billion)

TABLE 54. List of secondary sources, used in the study of global Antibiotics market

TABLE 55. List of primary sources, used in the study of global Antibiotics market

TABLE 56. Years considered for the study

TABLE 57. Exchange rates considered

Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Contact Us

Drop Us an email at

Similar Reports

Client Testimonials

Maria

David

Sara